Form 4: Omada Health Director Reports Stock Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


Omada Health Director Trevor Fetter reported transactions involving restricted stock units and common stock.

Summary

  • Trevor Fetter, a Director at Omada Health, Inc., reported a transaction on June 16, 2026.
  • This transaction involved the acquisition of 10,882 restricted stock units (RSUs) at a price of $0.
  • Following this, Fetter disposed of 111,200 shares of common stock.
  • Fetter also beneficially owns 23,533 shares of common stock directly.
  • Additionally, Fetter holds 111,200 shares indirectly through a family trust where he is a trustee and beneficiary.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions (acquisition of RSUs and disposal of shares) without clear positive or negative implications for the company's overall financial health or strategy.

Positives

  • Director Trevor Fetter acquired 10,882 RSUs, indicating continued equity participation.
  • The RSUs are set to vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting, subject to continued service.

Negatives

  • Director Trevor Fetter disposed of 111,200 shares of common stock.

Future Outlook

Restricted stock units acquired by Director Trevor Fetter are scheduled to fully vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, contingent upon continued service.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and trading activities of company directors and officers. This filing indicates a director's activity in Omada Health's stock.

Stakeholder Impact

  • Shareholders: The disposal of shares by a director may be interpreted in various ways, but without further context, it is a standard transaction. The acquisition of RSUs indicates continued alignment with the company's performance.

Next Steps

  • Vesting of 100% of RSUs on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting, subject to continued service.

Key Dates

DateDescription
06/16/2026Transaction Date for acquisition of RSUs and disposal of common stock.
06/18/2026Date of signature for the filing.
06/16/2027Vesting date for 100% of RSUs (first anniversary of grant date).
2027Potential vesting date for 100% of RSUs (date of the 2027 Annual Meeting).

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Transaction, Director, Restricted Stock Units, Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.